Khondrion
Nijmegen
About Khondrion
Khondrion is a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial disease. Founded by Professor Jan Smeitink, a world-leader in mitochondrial medicine, the company is advancing its proprietary science through a wholly-owned clinical and preclinical small molecule pipeline of potential medicines.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $9.5M
- Last round: Grant (May 2025)
- Website: khondrion.com
- Phone: +31 24 361 75 05
Industries & Categories
Biotechnology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/khondrion-46972 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.